IN2014CN03368A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03368A
IN2014CN03368A IN3368CHN2014A IN2014CN03368A IN 2014CN03368 A IN2014CN03368 A IN 2014CN03368A IN 3368CHN2014 A IN3368CHN2014 A IN 3368CHN2014A IN 2014CN03368 A IN2014CN03368 A IN 2014CN03368A
Authority
IN
India
Prior art keywords
surface marker
cell surface
purification
vectors
viral
Prior art date
Application number
Other languages
English (en)
Inventor
Chiara Bovolenta
Anna Stornaiuolo
Original Assignee
Molmed Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molmed Spa filed Critical Molmed Spa
Publication of IN2014CN03368A publication Critical patent/IN2014CN03368A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/65Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/13011Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13051Methods of production or purification of viral material
    • C12N2740/13052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/15011Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15051Methods of production or purification of viral material
    • C12N2740/15052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16051Methods of production or purification of viral material
    • C12N2740/16052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IN3368CHN2014 2011-10-05 2012-10-05 IN2014CN03368A (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11183937 2011-10-05
PCT/EP2012/069713 WO2013050523A1 (en) 2011-10-05 2012-10-05 Viral vectors purification system

Publications (1)

Publication Number Publication Date
IN2014CN03368A true IN2014CN03368A (https=) 2015-07-03

Family

ID=47071247

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3368CHN2014 IN2014CN03368A (https=) 2011-10-05 2012-10-05

Country Status (13)

Country Link
US (1) US20140248695A1 (https=)
EP (1) EP2764094A1 (https=)
JP (1) JP2014528729A (https=)
KR (1) KR20140068259A (https=)
CN (1) CN103842501B (https=)
AU (1) AU2012320480A1 (https=)
BR (1) BR112014008225A2 (https=)
CA (1) CA2848939A1 (https=)
IL (1) IL231876A0 (https=)
IN (1) IN2014CN03368A (https=)
RU (1) RU2607044C2 (https=)
WO (1) WO2013050523A1 (https=)
ZA (1) ZA201401481B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2480677T3 (en) 2010-09-02 2015-06-15 Molmed Spa Semi-stable production of lentiviral vectors
GB201310664D0 (en) 2013-06-14 2013-07-31 Mars Inc Feline taste receptors
BR112018070256A2 (pt) 2016-03-31 2019-01-29 Spark Therapeutics, Inc. processo de fabricação de raav totalmente escalável à base de colunas
JP2025143019A (ja) * 2024-03-18 2025-10-01 アイポア株式会社 ウイルスベクターの検査方法及び機械学習システム

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5654183A (en) * 1992-07-27 1997-08-05 California Institute Of Technology Genetically engineered mammalian neural crest stem cells
IT1261847B (it) 1993-09-01 1996-06-03 San Romanello Centro Fond Metodo per marcare cellule eucariote.
EP0781343B1 (de) * 1994-09-08 2003-07-02 Vision 7 GmbH Retrovirale vektorhybride und deren verwendung zum gentransfer
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
EP1284287A4 (en) * 2000-05-10 2004-10-13 Mitsubishi Pharma Corp METHOD FOR PRODUCING A VIRUS VECTOR
IL154987A0 (en) * 2000-09-22 2003-10-31 Virxsys Conditionally replicating viral vectors and their use
GB0224442D0 (en) * 2002-10-21 2002-11-27 Molmed Spa A delivery system
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase
JP3968383B2 (ja) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 血液細胞の新規分類法ならびにそれを利用したテイラーメード治療および予防
EP1739180A1 (en) * 2005-06-27 2007-01-03 Max-Delbrück-Centrum für Molekulare Medizin (MDC) T cell line-based packaging cell line for the production of retroviruses by enriching of CD3 expressing cells
JP4921083B2 (ja) * 2005-09-13 2012-04-18 タカラバイオ株式会社 レトロウィルス産生用無血清培地
WO2011060218A1 (en) * 2009-11-13 2011-05-19 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulated programmed death ligand-1
GB0920775D0 (en) * 2009-11-26 2010-01-13 King S College Cells
DK2480677T3 (en) 2010-09-02 2015-06-15 Molmed Spa Semi-stable production of lentiviral vectors
WO2012028680A1 (en) 2010-09-02 2012-03-08 Molmed Spa Semi-stable production of lentiviral vectors

Also Published As

Publication number Publication date
US20140248695A1 (en) 2014-09-04
CN103842501B (zh) 2017-12-08
IL231876A0 (en) 2014-05-28
AU2012320480A1 (en) 2014-04-24
WO2013050523A1 (en) 2013-04-11
JP2014528729A (ja) 2014-10-30
RU2014117466A (ru) 2015-11-10
KR20140068259A (ko) 2014-06-05
ZA201401481B (en) 2015-04-29
EP2764094A1 (en) 2014-08-13
RU2607044C2 (ru) 2017-01-10
NZ623092A (en) 2016-07-29
BR112014008225A2 (pt) 2017-04-11
CA2848939A1 (en) 2013-04-11
CN103842501A (zh) 2014-06-04

Similar Documents

Publication Publication Date Title
MX2015014720A (es) Mutante de epimerasa psicosa y metodo para preparar psicosa mediante el uso del mismo.
IN2014CN00688A (https=)
IN2015DN02771A (https=)
JO3306B1 (ar) تراكيب وطرق لطلاء الأظافر قابل للمعالجة بالأشعة فوق البنفسجية
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
SG10201806498RA (en) Cultured mammalian limbal stem cells, methods for generating the same, and uses thereof
UA114796C2 (uk) Спосіб підвищення ефективності трансдукції
AU2011356210A8 (en) Novel fucosyltransferases and their applications
PL3008172T3 (pl) Kompozycje pożywki hodowlanej do dojrzewania kardiomiocytów pochodzących z pluripotencjalnych ssaczych komórek macierzystych
MX2020009460A (es) Disminuir nivel de lactato e incrementar produccion de polipeptidos por regulacion a la baja de la expresion de lactato dehidrogenasa y piruvato dehidrogenasa quinasa.
IN2014CN01706A (https=)
ZA201302939B (en) Expression vector for high level expression of recombinant proteins
MX354516B (es) Vectores que codifican el factor de viabilidad de conos derivado de bastones.
WO2012102527A3 (ko) 조절자 T 세포에 특이적으로 존재하는 새로운 표면단백질 Lrig-1의 용도
PH12018500155A1 (en) Recombinant orf virus vector
MX2020003508A (es) Un factor de secrecion de proteinas con alta eficacia secretora y un vector de expresion que lo comprende.
GB2500161B (en) Enhancement of allogeneic hematopoietic stem cell transplantation
IN2014DN09367A (https=)
MX2016011465A (es) Drimenol-sintasas y metodos para producir drimenol.
IL230519B (en) Virus-based vector constructs used to transform eukaryotic cells
IN2014CN03368A (https=)
WO2014016383A3 (en) Glycoproteins for pseudotyping lentivectors
IN2014DN09097A (https=)
IN2014DN10111A (https=)
IN2014CN03414A (https=)